296 results
Page 2 of 15
8-K
EX-99.2
n2ycgh
29 Nov 23
Regulation FD Disclosure
8:00am
8-K
EX-99.1
q82kqwxuejtn3qgsv
13 Nov 23
Cocrystal Pharma Reports Third Quarter 2023 Financial Results and Provides Updates on its Antiviral Drug Development Programs
8:15am
8-K
EX-99.1
8bl8u4k1oz4my314463y
31 Oct 23
Cocrystal Pharma Receives UK MHRA Authorization to Initiate Its Phase 2a Influenza Human Challenge Trial with Oral PB2 Inhibitor CC-42344
8:00am
8-K
EX-99.1
te44qgb0ab1 njx9ep
16 Aug 23
Cocrystal Pharma Reports Second Quarter 2023 Financial Results and Provides Updates on its Antiviral Drug Development Programs
4:05pm
424B5
kq4r21 g7
15 Jun 23
Prospectus supplement for primary offering
4:54pm
UPLOAD
znm6kzz2
19 May 23
Letter from SEC
12:00am
8-K
EX-99.1
ouptmwcti k9
15 May 23
Cocrystal Pharma Reports First Quarter 2023 Financial Results and Provides Updates on its Antiviral Drug Development Programs
8:00am